Russell Investments Group Ltd. Acquires 481 Shares of Amedisys, Inc. $AMED

Russell Investments Group Ltd. increased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 50.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,440 shares of the health services provider’s stock after buying an additional 481 shares during the quarter. Russell Investments Group Ltd.’s holdings in Amedisys were worth $133,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Alpine Associates Management Inc. grew its position in Amedisys by 11.7% during the first quarter. Alpine Associates Management Inc. now owns 992,120 shares of the health services provider’s stock worth $91,900,000 after buying an additional 104,000 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Amedisys by 0.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 363,291 shares of the health services provider’s stock worth $33,652,000 after buying an additional 1,479 shares in the last quarter. Northern Trust Corp grew its position in Amedisys by 23.6% during the fourth quarter. Northern Trust Corp now owns 289,228 shares of the health services provider’s stock worth $26,259,000 after buying an additional 55,264 shares in the last quarter. Gotham Asset Management LLC grew its position in Amedisys by 77.4% during the fourth quarter. Gotham Asset Management LLC now owns 246,918 shares of the health services provider’s stock worth $22,418,000 after buying an additional 107,720 shares in the last quarter. Finally, CIBRA Capital Ltd grew its position in Amedisys by 359.7% during the first quarter. CIBRA Capital Ltd now owns 216,775 shares of the health services provider’s stock worth $20,080,000 after buying an additional 169,616 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded Amedisys from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 24th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Amedisys presently has an average rating of “Moderate Buy” and an average target price of $100.50.

Amedisys Stock Up 0.0%

NASDAQ AMED opened at $101.01 on Wednesday. The company has a market capitalization of $3.32 billion, a price-to-earnings ratio of 39.30, a PEG ratio of 1.34 and a beta of 0.89. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.26. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $101.02. The stock’s 50 day moving average is $98.94 and its two-hundred day moving average is $95.46.

Amedisys (NASDAQ:AMED) last announced its earnings results on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, topping the consensus estimate of $1.39 by $0.15. The business had revenue of $621.86 million for the quarter, compared to the consensus estimate of $614.61 million. Amedisys had a return on equity of 12.91% and a net margin of 3.56%.Amedisys’s revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.98 EPS. Equities analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.